U.S. Markets closed

Allergan to buy Woodlands-based drug company

Olivia Pulsinelli
American City Business Journals

Pharmaceutical giant Allergan PLC (AGN) will acquire The Woodlands-based Repros Therapeutics Inc. (RPRX), a company that develops drugs to treat male and female reproductive disorders, according to a Dec. 12 press release. A subsidiary of Ireland-based Allergan will purchase all of the outstanding shares of Repros common stock through a cash tender offer for 67 cents per share. Allergan — formerly Actavis PLC — reported net revenue of $14.57 billion in 2016, according to its annual report.